文献速递冠心病

老年心肌梗死合并高出血风险患者的完全血运重建与仅罪犯血管血运重建:一项随机临床试验

Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2024-01-01

该研究为FIRE随机临床试验的预设分析,纳入1445例75岁及以上心肌梗死合并多支血管病变患者,其中1025例(71%)符合高出血风险标准。高出血风险患者主要终点风险更高(HR 2.01,95%CI 1.47-2.76),而生理学指导的完全血运重建较仅罪犯血管策略显著降低高出血风险患者的主要终点(HR 0.73,95%CI 0.55-0.96)。

要点

  • 高出血风险在老年心梗多支病变患者中占71%,其不良事件风险显著增高。
  • 生理学指导完全血运重建可降低高出血风险患者主要终点风险(HR 0.73)。
  • 血运重建策略与高出血风险状态间无显著交互作用。

核心结论

  • 高出血风险状态在老年心梗患者中普遍存在,显著增加不良事件风险。
  • 生理学指导的完全血运重建较仅罪犯血管策略可有效减少缺血性不良事件,包括心血管死亡和心肌梗死。

研究设计与样本

  • FIRE随机临床试验的预设分析, investigator-initiated、开放标签、多中心研究。
  • 2019年7月至2021年10月于34个欧洲中心纳入75岁及以上心肌梗死合并多支血管病变患者。
  • 共纳入1445例患者(平均年龄81岁,标准差5岁;男性917例,占63%)。
  • 按学术研究联合会高出血风险文件将患者分为高出血风险或非高出血风险。
  • 生理学评估通过基于造影或基于导丝的方法进行。

主要发现

  • 1025例(71%)符合高出血风险标准。
  • 高出血风险患者主要终点风险更高(HR 2.01;95%CI 1.47-2.76)。
  • 高出血风险患者心血管死亡或心肌梗死风险更高(HR 1.89;95%CI 1.26-2.83)。
  • 高出血风险患者BARC 3至5型出血风险更高(HR 3.28;95%CI 1.40-7.64)。
  • 高出血风险患者中,生理学指导完全血运重建较仅罪犯血管策略显著降低主要终点(HR 0.73;95%CI 0.55-0.96)。

临床怎么用

  • 对老年心肌梗死合并多支血管病变患者应评估高出血风险状态。
  • 高出血风险患者仍可考虑生理学指导的完全血运重建以降低缺血事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with high bleeding risk (HBR) have a poor prognosis, and it is not known if they may benefit from complete revascularization after myocardial infarction (MI). OBJECTIVE: To investigate the benefit of physiology-guided complete revascularization vs a culprit-only strategy in patients with HBR, MI, and multivessel disease. DESIGN, SETTING, AND PARTICIPANTS: This was a prespecified analysis of the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) randomized clinical trial data. FIRE was an investigator-initiated, open-label, multicenter trial. Patients 75 years or older with MI and multivessel disease were enrolled at 34 European centers from July 2019 through October 2021. Physiology treatment was performed either by angiography- or wire-based assessment. Patients were divided into HBR or non-HBR categories in accordance with the Academic Research Consortium HBR document. INTERVENTIONS: Patients were randomized to either physiology-guided complete revascularization or culprit-only strategy. MAIN OUTCOMES AND MEASURES: The primary outcome comprised a composite of death, MI, stroke, or revascularization at 1 year. Secondary outcomes included a composite of cardiovascular death or MI and Bleeding Academic Research Consortium (BARC) types 3 to 5. RESULTS: Among 1445 patients (mean [SD] age, 81 [5] years; 917 male [63%]), 1025 (71%) met HBR criteria. Patients with HBR were at higher risk for the primary end point (hazard ratio [HR], 2.01; 95% CI, 1.47-2.76), cardiovascular death or MI (HR, 1.89; 95% CI, 1.26-2.83), and BARC types 3 to 5 (HR, 3.28; 95% CI, 1.40-7.64). The primary end point was significantly reduced with physiology-guided complete revascularization as compared with culprit-only strategy in patients with HBR (HR, 0.73; 95% CI, 0.55-0.96). No indication of interaction was noted between revascularization strategy and HBR status for primary and secondary end points. CONCLUSIONS AND RELEVANCE: HBR status is prevalent among older patients with MI, significantly increasing the likelihood of adverse events. Physiology-guided complete revascularization emerges as an effective strategy, in comparison with culprit-only revascularization, for mitigating ischemic adverse events, including cardiovascular death and MI. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03772743.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Erriquez, Campo, Guiducci, et al. Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 38717753. doi:10.1001/jamacardio.2024.0804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。